Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation

Journal of Virology

Volumn 70, Issue 10, 1996, Pages 6987-6993

  Stöppler, Melissa Conrad ^a   Ching, Karen ^b   Stöppler, Hubert ^a   Clancy, Kelly ^b   Schlegel, Richard ^a   Icenogle, Joseph ^b  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; VIRUS PROTEIN;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; KERATINOCYTE; MALE; PREPUCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; UTERINE CERVIX EPITHELIUM; VIRUS CELL TRANSFORMATION; VIRUS PATHOGENESIS; WART VIRUS;

EID: 0029818001     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.10.6987-6993.1996     Document Type: Article

References (55)

1. Band, V., D. Zajchowski, V. Kulesa, and R. Sager. 1990. Human papillomavirus DNAs immortalize normal human mammary epithelial cells and reduce their growth factor requirements. Proc. Natl. Acad. Sci. USA 87:463-467.
2. Barbosa, M. S., and R. Schlegel. 1989. The E6 and E7 genes of HPV-18 arc sufficient for inducing two-stage in vitro transformation of human keratinocytes. Oncogene 4:1529-1532.
3. Bartholomew, J. S., S. N. Stacey, B. Coles, S. J. Burt, J. R. Arrand, and P. L. Stern. 1994. Identification of a naturally processed HLA A0201-restricted viral peptide from cells expressing human papillomavirus type 16 E6 oncoprotein. Eur. J. Immunol. 24:3175-3179.
4. Bedell, M., K. Jones, and L. Laimins. 1987. The E6-E7 region of human papillomavirus type 18 is sufficient for transformation of NIH 3T3 and Rat-1 cells. J. Virol. 61:3635-3640.
5. Boshart, M., L. Gissmann, H. Ikenberg, A. Kleinheinz, W. Scheurlen, and H. zur Hausen. 1984. A new type of papillomavirus DNA and its prevalence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J. 3:1151-1157.
6. Chan, S.-Y., L. Ho, C.-K. Ong, V. Chow, B. Drescher, M. Dürst, J. ter Meulen, L. Villa, J. Luande, H. N. Mgaya, and H.-L. Bernard. 1992. Molecular variants of human papillomavirus type 16 from four continents suggest ancient pandemic spread of the virus and its coevolution with humankind. J. Virol. 66:2057-2066.
7. Chen, J. J., C. E. Reid, V. Band, and E. J. Androphy. 1995. Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein. Science 269:529-531.
8. Chesters, P. M., K. H. Vousden, C. Edmonds, and D. J. McCance. 1990. Analysis of human papillomavirus type 16 open reading frame E7 immortalizing function in rat embryo fibroblast cells. J. Gen. Virol. 71:449-453.
9. Crook, T., J. A. Tidy, and K. H. Vousden. 1991. Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation. Cell 67:547-556.
10. Deau, M.-C., M. Favre, and G. Orth. 1991. Genetic heterogeneity among human papillomavirus (HPV) associated with epidermodysplasia verruciformis: evidence for multiple allelic forms of HPV5 and HPV8 E6 genes. Virology 184:492-503.
11. de Villiers, E.-M. 1994. Human pathogenic papillomavirus types: an update, p. 1-12. In H. zur Hausen (ed.), Human pathogenic papillomaviruses. Springer-Verlag, Berlin.
12. Dürst, M., L. Gissman, H. Ikenberg, and H. zur Hausen. 1983. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc. Natl. Acad. Sci. USA 80: 3812-3815.
13. Ellis, J. R. M., P. J. Keating, J. Baird, E. F. Hounsell, D. V. Renouf, M. Rowe, D. Hopkins. M. F. Duggan-Keen, J. S. Bartholomew, L. S. Young, and P. L. Stern. 1995. The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer. Nat. Med. 1:464-470.
14. Eschle, D., M. Dürst, J. ter Meulen, J. Luande, H. C. Eberhardt, M. Pawlita, and L. Gissmann. 1992. Geographical dependence of sequence variation in the E7 gene of human papillomavirus type 16. J. Gen. Virol. 73:1829-1832.
15. Foster, S. A., G. W. Demers, B. G. Etscheid, and D. A. Galloway. 1994. The ability of human papillomavirus E6 proteins to target p53 for degradation in vivo correlates with their ability to abrogate actinomycin D-induced growth arrest. J. Virol. 68:5698-5705.
16. Fujinaga, Y., K. Okazawa, A. Mishikawa, Y. Yamakawa, M. Fukushima, I. Kato, and K. Fujinaga. 1994. Sequence variation of human papillomavirus type 16 E7 in preinvasive and invasive cervical neoplasias. Virus Genes 9:85-92.
17. Gissmann, L., M. Boshart, M. Dürst, H. Ikenberg, D. Wagner, and H. zur Hausen. 1984. Presence of human papillomavirus (HPV) DNA in genital tumours. J. Invest. Dermatol. 83:265-288.
18. Green, S., I. Issemann, and E. Sheer. 1988. A versatile in vivo and in vitro eukaryotic expression vector for protein engineering. Nucleic Acids Res. 16:369.
19. Halbert, C. L., G. W. Demers, and D. A. Galloway. 1992. The E6 and E7 genes of human papillomavirus type 6 have weak immortalizing activity in human epithelial cells. J. Virol. 66:2125-2134.
20. Hawley-Nelson, P., K. H. Vousden, N. L. Hubbert, D. R. Lowy, and J. T. Schiller. 1989. HPV 16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J. 8:3905-3910.
21. Ho, L., S.-Y. Chan, R. D. Burk, B. C. Das, K. Fujinaga, J. P. Icenogle, T. Kahn, N. Kiviat, W. Lancaster, P. Mavromara-Nazos, V. Labropoulou, S. Mitrani-Rosenbaum, B. Norrild, M. R. Pillai, J. Stoerker, K. Syrjaenen, S. Syrjaenen, S.-K. Tay, L. L. Villa, C. M. Wheeler, A.-L. Williamson, and H.-U. Bernard. 1993. The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations. J. Virol. 67:6413-6423.
22. Ho, L., S.-Y. Chan, V. Chow, T. Chong, S.-K. Tay, L. L. Villa, and H.-U. Bernard. 1991. Sequence variants of human papillomavirus type 16 in clinical samples permit verification and extension of epidemiological studies and construction of a phylogenetic tree. J. Clin. Microbiol. 29:1765-1772.
23. Ho, L., S.-K. Tay, S.-Y. Chan, and H.-U. Bernard. 1993. Sequence variants of human papillomavirus type 16 from couples suggest sexual transmission with low infectivity and polyclonality in genital neoplasia. J. Infect. Dis. 168:803-809.
24. Hoppe-Seyler, F., and K. Butz. 1993. Repression of endogenous p53 transactivation function in HeLa cervical carcinoma cells by human papillomavirus type 16 E6, human mdm-2, and mutant p53. J. Virol. 67:3111-3117.
25. Hudson, J. B., M. A. Bedell, D. J. McCance, and L. A. Laimins. 1990. Immortalization and altered differentiation of human keratinocytes in vitro by the E6 and E7 open reading frames of human papillomavirus type 18. J. Virol. 64:519-526.
26. Huibregtse, J. M., M. Scheffner, and P. M. Howley. 1991. A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J. 10:4129-4135.
27. Huibregtse, J. M., M. Scheffner, and P. M. Howley. 1993. Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53. Mol. Cell. Biol. 13:775-784.
28. Huibregtse, J. M., M. Scheffner, and P. M. Howley. 1993. Localization of the E6-AP regions that direct human papillomavirus E6 binding, association with p53, and ubiquitination of associated proteins. Mol. Cell. Biol. 13:4918-4927.
29. Icenogle, J. P. Unpublished data.
30. Icenogle, J. P., M. Laga, D. Miller, A. T. Manoka, R. A. Tucker, and W. C. Reeves. 1992. Genotypes and sequence variants of human papillomavirus DNAs from human immunodeficiency virus type 1-infected women with cervical intraepithelial neoplasia. J. Infect. Dis. 166:1210-1216.
31. Icenogle, J. P., P. Sathya, D. L. Miller, R. A. Tucker, and W. E. Rawls. 1991. Nucleotide and amino acid sequence variation in the L1 and E7 open reading frames of human papillomavirus type 6 and type 16. Virology 184: 101-107.
32. Kadish, A. Personal communication.
33. Kanda, T., S. Watanabe, and K. Yoshiike. 1988. Immortalization of primary rat cells by human papillomavirus type 16 subgenomic fragments controlled by the SV40 promoter. Virology 165:321-325.
34. Kessis, T. D., R. J. Slebos, W. G. Nelson, M. B. Kastan, B. S. Plunkett, S. M. Han, A. T. Lorincz, L. Hedrick, and K. R. Cho. 1993. Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. Proc. Natl. Acad. Sci. USA 90:3988-3992.
35. Kozak, M. 1987. At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells. J. Mol. Biol. 196:947-950.
36. Laga, M., J. P. Icenogle, R. Marsella, A. T. Manoka, N. Nzila, R. W. Ryder, S. H. Vermund, W. L. Heyward, A. Nelson, and W. C. Reeves. 1992. Genital papillomavirus infection and cervical dysplasia-opportunistic complications of HIV infection. Int. J. Cancer 50:45-48.
37. Lechner, M. S., and L. A. Laimins. 1994. Inhibition of p53 DNA binding by human papillomavirus E6 proteins. J. Virol. 68:4262-4273.
38. Lechner, M. S., D. H. Mack, A. B. Finicle, T. Crook, K. H. Vousden, and L. A. Laimins. 1992. Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53-mediated repression of transcription. EMBO J. 11:3045-3052.
39. Li, X., and P. Coffino. 1996. High-risk human papillomavirus E6 protein has two distinct binding sites within p53. of which only one determines degradation. J. Virol. 70:4509-4516.
40. Liu, Z., J. Ghai, R. S. Ostrow, R. C. McGlennen, and A. J. Faras. 1994. The E6 gene of human papillomavirus type 16 is sufficient for transformation of baby rat kidney cells in cotransfection with activated Ha-ras. Virology 201: 388-396.
41. Mietz, J. A., T. Unger, J. M. Huibregtse, and P. M. Howley. 1992. The transcriptional transactivation function of wild-type p53 is inhibited by SV40 large T-antigen and by HPV-16 E6 oncoprotein. EMBO J. 11:5013-5020.
42. Müller, M., H. Gausepohl, G. de Martynoff, R. Frank, R. Brasseur, and L. Gissmann. 1990. Identification of seroreactive regions of the human papillomavirus type 16 protein E4, E6, E7 and L1. J. Gen. Virol. 71:2709-2717.
43. Münger, K., W. C. Phelps, V. Bubb, P. H. Howley, and R. Schlegel. 1989. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J. Virol. 63:4417-4421.
44. Muñoz, N., F. X. Bosch, S. de Sanjosé, L. Tafur, I. Izarzugaza, M. Gili, P. Viladiu, C. Navarro, C. Martos, N. Ascunce, L. C. Gonzalez, J. M. Kaldor, E. Guerrero, A. Lörincz, M. Santamaria, P. Alonso de Ruiz, N. Aristizabal, and K. Shah. 1992. The causal link between human papillomavirus and invasive cervical cancer: a population-based case-control study in Colombia and Spain. Int. J. Cancer 52:743-749.
45. Ong, C-K., S.-Y. Chan, M. S. Campo, K. Fujinaga, P. Mavromara-Nazos, V. Labropoulo, H. Pfister, S.-K. Tay, J. ter Meulen, L. L. Villa, and H.-U. Bernard. 1993. Evolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups. J. Virol. 67:6424-6431.
46. Rolfe, M., P. Beer-Romero, S. Glass, J. Eckstein, I. Berdo, A. Theodoras, M. Pagano, and G. Draetta. 1995. Reconstitution of p53-ubiquitinylation reactions from purified components: the role of human ubiquitin-conjugating enzyme UBC4 and E6-associated protein (E6AP). Proc. Natl. Acad. Sci. USA 92:3264-3268.
47. Scheffner, M., B. A. Werness, J. M. Huibregtse, A. J. Levine, and P. M. Howley. 1990. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129-1136.
48. Schlegel, R., W. C. Phelps, Y. L. Zhang, and M. Barbosa. 1988. Quantitative keratinocyte assay detects two biological activities of human papillomavirus DNA and identifies viral types associated with cervical carcinoma. EMBO J. 7:3181-3187.
49. Sedman, S. A., M. S. Barbosa, W. C. Vass, N. L. Hubbert, J. A. Haas, D. R. Lowy, and J. T. Schiller. 1991. The full-length E6 protein of human papillomavirus type 16 has transforming and trans-activating activities and cooperates with E7 to immortalize keratinocytes in culture. J. Virol. 65:4860-4866.
50. Seedorf, K., G. Krämmer, M. Dürst, S. Suhai, and W. G. Röwekamp. 1985. Human papillomavirus type 16 DNA sequence. Virology 145:181-185.
51. Slebos, R. J. C., T. D. Kessis, A. W. Chen, S. M. Han, L. Hedrick, and K. R. Cho. 1995. Functional consequences of directed mutations in human papillomavirus E6 proteins: abrogation of p53-mediated cell cycle arrest correlates with p53 binding and degradation in vitro. Virology 208:111-120.
52. Storey, A., and L. Banks. 1993. Human papillomavirus type 16 E6 gene cooperates with EJ-ras to immortalize primary mouse cells. Oncogene 8:919-924.
53. Yamada, T., C. M. Wheeler, A. L. Halpern, A.-C. M. Stewart, A. Hildesheim, and S. A. Jenison. 1995. Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments. J. Virol. 69:7743-7753.
54. Yasumoto, S., A. Burkhardt, J. Doniger, and J. DiPaolo. 1986. Human papillomavirus type 16 DNA-induced malignant transformation of NIH 3T3 cells. J. Virol. 57:572-577.
55. zur Hausen, H. 1991. Human papillomaviruses in the pathogenesis of human anogenital cancer. Virology 184:9-13.